loader
Please Wait
Applying Filters...

Suanfarma Suanfarma

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    List of Certificates of Suitability (CEPs) for r1_cep_2003_028___rev_02 Active Pharmaceutical Ingredient (API) issued by the EDQM. Original Data: EDQM Database

    Client Virtual Booth
    Menu

    Gelita Health GmbH

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    EXCIPIENTS

    PharmaCompass

    Inke S.A: APIs manufacturing plant.

    Send me more info on How To Grow My Business Digitally?

    Left Arrow
    Right Arrow
    Filters Filter
    Cross PopUp
    FILTER :

    filter

    01 GELITA AG Eberbach DE (1)

    filter

    01 Gelatin, VFB Limed Bone Gelatine (1)

    filter

    01 Germany (1)

    filter

    01 Valid (1)

    ListList of Suppliers
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us

    GELITA AG Eberbach DE

    Contact Supplier
      Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
      Post an Enquiry Post an Enquiry
      Flag Germany
      Virtual Booth Virtual Booth
      Digital Content Digital Content

      Gelatin, VFB Limed Bone Gelatine

      PDF Supplier PDF
      URL Supplier Web Content
      R1-CEP 2003-028 - Rev 02
      Valid
      TSE
      2019-02-12
      330
      ASK
      US
      PHARMACOMPASS
      Upload
      your Marketing & Sales content

      Looking for Certificates of Suitability (CEPs) for R1-CEP 2003-028 - Rev 02 of Gelita Ag Eberbach De

      Looking for Certificates of Suitability (CEPs) for R1-CEP 2003-028 - Rev 02 of Gelita Ag Eberbach De 1

      20

      Gelita Ag Eberbach De, based in Germany, is a pharmaceutical company.

      One of their significant offerings is Gelatin, VFB Limed Bone Gelatine, supported by a 'Valid' Certificate of Suitability (CEP) with the number R1-CEP 2003-028 - Rev 02

      This TSE Type CEP, issued on February 12, 2019, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.

      Substance Number 330 associated with this CEP further emphasizes

      Post Enquiry
      POST ENQUIRY